Zenagamtide
A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semagl
Novo Nordisk · Phase 1 · Recruiting · Enrollment 60
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Semaglutide and Zenagamtide | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.